Symbol:
Myocd
Name:
myocardin
RGD ID:
631347
Description:
Predicted to enable several functions, including R-SMAD binding activity; enzyme binding activity; and transcription coactivator activity. Involved in several processes, including cardiocyte differentiation; hepatic stellate cell activation; and positive regulation of vascular associated smooth muscle cell migration. Located in cytoplasm and nucleus. Part of protein-DNA complex. Used to study congenital heart disease. Human ortholog(s) of this gene implicated in congenital megabladder and dilated cardiomyopathy. Orthologous to human MYOCD (myocardin); PARTICIPATES IN platelet-derived growth factor signaling pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; ammonium chloride; bis(2-ethylhexyl) phthalate.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
Mycd; transcription factor myocardin
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
MYOCD (myocardin)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Myocd (myocardin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Myocd (myocardin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
MYOCD (myocardin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
MYOCD (myocardin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Myocd (myocardin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
MYOCD (myocardin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
MYOCD (myocardin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Myocd (myocardin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
MYOCD (myocardin)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Myocd (myocardin)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
Mrtf
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
myocd
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 50,332,356 - 50,426,819 (-) NCBI GRCr8 mRatBN7.2 10 49,833,219 - 49,928,806 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 49,836,641 - 49,927,627 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 54,505,304 - 54,596,319 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 53,995,291 - 54,086,296 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 49,509,995 - 49,600,991 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 51,682,053 - 51,781,458 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 51,683,540 - 51,778,986 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 51,439,727 - 51,534,567 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 51,496,223 - 51,588,226 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 51,509,851 - 51,601,849 (-) NCBI Celera 10 49,052,568 - 49,143,747 (-) NCBI Celera Cytogenetic Map 10 q24 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Myocd Rat (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1344327 155230825 (-)-epigallocatechin 3-gallate inhibits the reaction [angiotensin II decreases expression of MYOCD protein in vascular smooth more ... RGD Myocd Rat 1,2-dimethylhydrazine decreases expression ISO RGD:1614957 6480464 1,2-Dimethylhydrazine results in decreased expression of MYOCD mRNA CTD PMID:22206623 Myocd Rat 17alpha-ethynylestradiol multiple interactions ISO RGD:1614957 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MYOCD mRNA CTD PMID:17942748 Myocd Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1614957 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MYOCD mRNA; Tetrachlorodibenzodioxin promotes the more ... CTD PMID:17942748|PMID:19654925 Myocd Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYOCD mRNA CTD PMID:33387578 Myocd Rat 4,4'-sulfonyldiphenol increases expression ISO RGD:1614957 6480464 bisphenol S results in increased expression of MYOCD mRNA CTD PMID:30951980 Myocd Rat aflatoxin B1 increases methylation ISO RGD:1344327 6480464 Aflatoxin B1 results in increased methylation of MYOCD gene CTD PMID:27153756 Myocd Rat Aflatoxin B2 alpha increases methylation ISO RGD:1344327 6480464 aflatoxin B2 results in increased methylation of MYOCD intron CTD PMID:30157460 Myocd Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MYOCD mRNA CTD PMID:16483693 Myocd Rat angiotensin II decreases expression ISO RGD:1344327 155230825 angiotensin II decreases expression of MYOCD mRNA and protein in vascular smooth muscle cell RGD Myocd Rat arsane affects methylation ISO RGD:1344327 6480464 Arsenic affects the methylation of MYOCD gene CTD PMID:25304211 Myocd Rat arsane multiple interactions ISO RGD:1344327 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Myocd Rat arsenic atom affects methylation ISO RGD:1344327 6480464 Arsenic affects the methylation of MYOCD gene CTD PMID:25304211 Myocd Rat arsenic atom multiple interactions ISO RGD:1344327 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Myocd Rat arsenous acid increases expression ISO RGD:1344327 6480464 Arsenic Trioxide results in increased expression of MYOCD mRNA CTD PMID:26705709 Myocd Rat benzo[a]pyrene multiple interactions ISO RGD:1614957 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MYOCD mRNA]; Benzo(a)pyrene promotes the more ... CTD PMID:19654925|PMID:22228805 Myocd Rat benzo[a]pyrene affects methylation ISO RGD:1344327 6480464 Benzo(a)pyrene affects the methylation of MYOCD intron; Benzo(a)pyrene affects the methylation of MYOCD promoter CTD PMID:27901495|PMID:30157460 Myocd Rat benzo[a]pyrene increases methylation ISO RGD:1344327 6480464 Benzo(a)pyrene results in increased methylation of MYOCD 5' UTR CTD PMID:27901495 Myocd Rat benzo[a]pyrene decreases expression ISO RGD:1344327 6480464 Benzo(a)pyrene results in decreased expression of MYOCD mRNA CTD PMID:22178795 Myocd Rat benzo[a]pyrene increases expression ISO RGD:1614957 6480464 Benzo(a)pyrene results in increased expression of MYOCD mRNA CTD PMID:22228805 Myocd Rat benzo[a]pyrene increases expression ISO RGD:1344327 6480464 Benzo(a)pyrene results in increased expression of MYOCD mRNA CTD PMID:22316170|PMID:32234424 Myocd Rat benzo[a]pyrene diol epoxide I affects expression ISO RGD:1344327 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of MYOCD mRNA CTD PMID:20382639 Myocd Rat bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of MYOCD mRNA CTD PMID:26472102 Myocd Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of MYOCD mRNA CTD PMID:26496021 Myocd Rat bisphenol A decreases methylation ISO RGD:1344327 6480464 bisphenol A results in decreased methylation of MYOCD gene CTD PMID:31601247 Myocd Rat bisphenol A increases expression ISO RGD:1614957 6480464 bisphenol A results in increased expression of MYOCD mRNA CTD PMID:30951980 Myocd Rat bisphenol A decreases expression ISO RGD:1344327 6480464 bisphenol A results in decreased expression of MYOCD mRNA CTD PMID:27685785 Myocd Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MYOCD mRNA CTD PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998 Myocd Rat bisphenol F increases expression ISO RGD:1614957 6480464 bisphenol F results in increased expression of MYOCD mRNA CTD PMID:30951980 Myocd Rat Butylbenzyl phthalate decreases expression EXP 6480464 butylbenzyl phthalate results in decreased expression of MYOCD mRNA CTD PMID:26472102 Myocd Rat cadmium atom multiple interactions ISO RGD:1344327 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MYOCD more ... CTD PMID:35301059 Myocd Rat cadmium dichloride multiple interactions ISO RGD:1344327 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MYOCD more ... CTD PMID:35301059 Myocd Rat carbon nanotube increases expression ISO RGD:1614957 6480464 Nanotubes, Carbon analog results in increased expression of MYOCD mRNA; Nanotubes, Carbon results in increased more ... CTD PMID:25554681 Myocd Rat carbon nanotube increases expression ISO RGD:1344327 6480464 Nanotubes, Carbon results in increased expression of MYOCD mRNA CTD PMID:31047983 Myocd Rat chlorpyrifos decreases expression ISO RGD:1614957 6480464 Chlorpyrifos results in decreased expression of MYOCD mRNA CTD PMID:37019170 Myocd Rat cisplatin multiple interactions ISO RGD:1344327 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of MYOCD mRNA CTD PMID:27392435 Myocd Rat cisplatin decreases expression ISO RGD:1344327 6480464 Cisplatin results in decreased expression of MYOCD mRNA CTD PMID:27392435 Myocd Rat crocidolite asbestos decreases expression ISO RGD:1344327 6480464 Asbestos, Crocidolite results in decreased expression of MYOCD mRNA CTD PMID:18687144 Myocd Rat cyclosporin A affects expression ISO RGD:1344327 6480464 Cyclosporine affects the expression of MYOCD mRNA CTD PMID:33631201 Myocd Rat diarsenic trioxide increases expression ISO RGD:1344327 6480464 Arsenic Trioxide results in increased expression of MYOCD mRNA CTD PMID:26705709 Myocd Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of MYOCD mRNA; Dibutyl Phthalate results in decreased expression more ... CTD PMID:26472102|PMID:35926758 Myocd Rat diethyl phthalate decreases expression EXP 6480464 diethyl phthalate results in decreased expression of MYOCD mRNA CTD PMID:26472102 Myocd Rat Dimethyl phthalate decreases expression EXP 6480464 dimethyl phthalate results in decreased expression of MYOCD mRNA CTD PMID:26472102 Myocd Rat dipentyl phthalate decreases expression EXP 6480464 di-n-pentyl phthalate results in decreased expression of MYOCD mRNA CTD PMID:26472102 Myocd Rat dorsomorphin multiple interactions ISO RGD:1344327 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Myocd Rat doxorubicin multiple interactions EXP 6480464 paeonol affects the reaction [Doxorubicin results in decreased expression of MYOCD mRNA] CTD PMID:31307187 Myocd Rat doxorubicin decreases expression ISO RGD:1344327 6480464 Doxorubicin results in decreased expression of MYOCD mRNA CTD PMID:29803840 Myocd Rat doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of MYOCD mRNA CTD PMID:31307187 Myocd Rat entinostat decreases expression ISO RGD:1344327 6480464 entinostat results in decreased expression of MYOCD mRNA CTD PMID:27188386 Myocd Rat fonofos increases methylation ISO RGD:1344327 6480464 Fonofos results in increased methylation of MYOCD promoter CTD PMID:22847954 Myocd Rat formaldehyde increases expression ISO RGD:1344327 6480464 Formaldehyde results in increased expression of MYOCD mRNA CTD PMID:28937961 Myocd Rat furan increases methylation EXP 6480464 furan results in increased methylation of MYOCD gene CTD PMID:22079235 Myocd Rat geldanamycin increases expression ISO RGD:1344327 6480464 geldanamycin results in increased expression of MYOCD mRNA CTD PMID:26705709 Myocd Rat genistein increases expression ISO RGD:1614957 6480464 Genistein results in increased expression of MYOCD mRNA CTD PMID:32186404 Myocd Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of MYOCD mRNA CTD PMID:33387578 Myocd Rat manganese atom multiple interactions ISO RGD:1344327 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Myocd Rat manganese(0) multiple interactions ISO RGD:1344327 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Myocd Rat manganese(II) chloride multiple interactions ISO RGD:1344327 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Myocd Rat nickel atom decreases expression ISO RGD:1344327 6480464 Nickel results in decreased expression of MYOCD mRNA CTD PMID:24768652|PMID:25583101 Myocd Rat nickel sulfate increases expression ISO RGD:1344327 6480464 nickel sulfate results in increased expression of MYOCD mRNA CTD PMID:22714537 Myocd Rat nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of MYOCD mRNA CTD PMID:33484710 Myocd Rat ozone multiple interactions ISO RGD:1614957 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MYOCD more ... CTD PMID:34911549 Myocd Rat Paeonol increases expression EXP 6480464 paeonol results in increased expression of MYOCD mRNA CTD PMID:31307187 Myocd Rat Paeonol multiple interactions EXP 6480464 paeonol affects the reaction [Doxorubicin results in decreased expression of MYOCD mRNA] CTD PMID:31307187 Myocd Rat panobinostat increases expression ISO RGD:1344327 6480464 panobinostat results in increased expression of MYOCD mRNA CTD PMID:26272509 Myocd Rat panobinostat multiple interactions ISO RGD:1344327 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Myocd Rat parathion increases methylation ISO RGD:1344327 6480464 Parathion results in increased methylation of MYOCD promoter CTD PMID:22847954 Myocd Rat phenylephrine multiple interactions EXP 6480464 MYOCD protein affects the reaction [Phenylephrine results in increased expression of ACTA2 mRNA]; MYOCD protein more ... CTD PMID:14676212|PMID:16556869 Myocd Rat phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of MYOCD mRNA; Phenylephrine results in increased expression of MYOCD more ... CTD PMID:16556869 Myocd Rat phenylmercury acetate increases expression ISO RGD:1344327 6480464 Phenylmercuric Acetate results in increased expression of MYOCD mRNA CTD PMID:26272509 Myocd Rat phenylmercury acetate multiple interactions ISO RGD:1344327 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Myocd Rat pirinixic acid increases expression ISO RGD:1614957 6480464 pirinixic acid results in increased expression of MYOCD mRNA CTD PMID:16985257 Myocd Rat progesterone increases expression ISO RGD:1344327 6480464 Progesterone results in increased expression of MYOCD mRNA CTD PMID:20864642 Myocd Rat resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of MYOCD mRNA CTD PMID:20797428 Myocd Rat SB 203580 multiple interactions ISO RGD:1344327 6480464 SB 203580 inhibits the reaction [TGFB1 protein results in increased expression of MYOCD mRNA] CTD PMID:21712382 Myocd Rat SB 431542 multiple interactions ISO RGD:1344327 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Myocd Rat sodium arsenate increases expression ISO RGD:1614957 6480464 sodium arsenate results in increased expression of MYOCD mRNA CTD PMID:21795629 Myocd Rat sodium arsenite decreases expression ISO RGD:1344327 6480464 sodium arsenite results in decreased expression of MYOCD mRNA CTD PMID:34032870 Myocd Rat sodium arsenite multiple interactions ISO RGD:1344327 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Myocd Rat sulforaphane decreases expression ISO RGD:1344327 6480464 sulforaphane results in decreased expression of MYOCD mRNA CTD PMID:31838189 Myocd Rat sunitinib decreases expression ISO RGD:1344327 6480464 Sunitinib results in decreased expression of MYOCD mRNA CTD PMID:31533062 Myocd Rat terbufos increases methylation ISO RGD:1344327 6480464 terbufos results in increased methylation of MYOCD promoter CTD PMID:22847954 Myocd Rat testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of MYOCD mRNA CTD PMID:26496021 Myocd Rat titanium dioxide decreases expression ISO RGD:1614957 6480464 titanium dioxide results in decreased expression of MYOCD mRNA CTD PMID:23557971 Myocd Rat trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of MYOCD gene CTD PMID:27618143 Myocd Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of MYOCD mRNA CTD PMID:33387578 Myocd Rat trichostatin A increases expression ISO RGD:1344327 6480464 trichostatin A results in increased expression of MYOCD mRNA CTD PMID:24935251|PMID:26705709 Myocd Rat triclosan decreases expression ISO RGD:1344327 6480464 Triclosan results in decreased expression of MYOCD mRNA CTD PMID:30510588 Myocd Rat UTP multiple interactions EXP 6480464 Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of MYL2 protein]; Uridine more ... CTD PMID:14676212 Myocd Rat valproic acid affects expression ISO RGD:1344327 6480464 Valproic Acid affects the expression of MYOCD mRNA CTD PMID:25979313 Myocd Rat valproic acid increases expression ISO RGD:1344327 6480464 Valproic Acid results in increased expression of MYOCD mRNA CTD PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:26705709|PMID:28001369 Myocd Rat valproic acid multiple interactions ISO RGD:1344327 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Myocd Rat valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of MYOCD mRNA CTD PMID:35594946 Myocd Rat XL147 multiple interactions ISO RGD:1614957 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOCD mRNA CTD PMID:27935865
Biological Process
Only show annotations with direct experimental evidence (0 objects hidden)
Myocd Rat cardiac muscle cell apoptotic process acts_upstream_of ISO RGD:1614957 1624291 MGI:3773717 PMID:19850880 RGD PMID:19850880 Myocd Rat cardiac muscle cell differentiation involved_in ISO RGD:1614957 1624291 PMID:11439182 RGD PMID:11439182 Myocd Rat cardiac muscle cell differentiation acts_upstream_of_or_within ISO RGD:1614957 1624291 PMID:14645532 RGD PMID:14645532 Myocd Rat cardiac muscle cell differentiation involved_in IBA MGI:2137495|PANTHER:PTN002736064|RGD:631347 1600115 GO_REF:0000033 GO_Central GO_REF:0000033 Myocd Rat cardiac muscle cell myoblast differentiation involved_in ISO RGD:1344327 1624291 PMID:15907818 RGD PMID:15907818 Myocd Rat cardiac vascular smooth muscle cell differentiation involved_in IDA 8554320 PMID:16151017 BHF-UCL Myocd Rat cardiac ventricle development acts_upstream_of_or_within ISO RGD:1614957 1624291 MGI:3052940 PMID:21357509 RGD PMID:21357509 Myocd Rat cell growth involved in cardiac muscle cell development IMP 5132877 RGD Myocd Rat cellular response to angiotensin IEP 529389387 RGD Myocd Rat cellular response to angiotensin IEP 401793757 RGD Myocd Rat cellular response to growth factor stimulus IEP 5132874 RGD Myocd Rat cellular response to hypoxia IEP 5132874 RGD Myocd Rat cellular response to transforming growth factor beta stimulus IEP 529389387 RGD Myocd Rat chromatin organization acts_upstream_of_or_within ISO RGD:1614957 1624291 PMID:15601857 RGD PMID:15601857 Myocd Rat digestive tract development acts_upstream_of_or_within ISO RGD:1614957 1624291 MGI:3052940 PMID:21357509 RGD PMID:21357509 Myocd Rat ductus arteriosus closure acts_upstream_of_or_within ISO RGD:1614957 1624291 MGI:3773718 PMID:18188448 RGD PMID:18188448 Myocd Rat heart development acts_upstream_of_or_within ISO RGD:1614957 1624291 PMID:11439182 RGD PMID:11439182 Myocd Rat heart development involved_in ISO RGD:1614957 1624291 PMID:24068960 RGD PMID:24068960 Myocd Rat hepatic stellate cell activation IMP 5132876 RGD Myocd Rat hepatic stellate cell activation IEP 529195969 RGD Myocd Rat lung alveolus development acts_upstream_of_or_within ISO RGD:1614957 1624291 MGI:3052940 PMID:21357509 RGD PMID:21357509 Myocd Rat negative regulation of amyloid-beta clearance acts_upstream_of ISO RGD:1344327 1624291 PMID:19098903 RGD PMID:19098903 Myocd Rat negative regulation of cardiac muscle cell apoptotic process acts_upstream_of_or_within ISO RGD:1614957 1624291 MGI:3773717 PMID:19850880 RGD PMID:19850880 Myocd Rat negative regulation of cell adhesion molecule production acts_upstream_of ISO RGD:1614957 1624291 PMID:28342807 RGD PMID:28342807 Myocd Rat negative regulation of cell population proliferation involved_in ISO RGD:1344327 1624291 PMID:18451334 RGD PMID:18451334 Myocd Rat negative regulation of myotube differentiation acts_upstream_of_or_within ISO RGD:1614957 1624291 MGI:3849559 PMID:17940050 RGD PMID:17940050 Myocd Rat negative regulation of platelet-derived growth factor receptor-beta signaling pathway involved_in ISO RGD:1614957 1624291 PMID:23825366 RGD PMID:23825366 Myocd Rat negative regulation of skeletal muscle cell differentiation involved_in ISO RGD:1344327 1624291 PMID:18451334 RGD PMID:18451334 Myocd Rat negative regulation of transcription by RNA polymerase II acts_upstream_of_or_within ISO RGD:1614957 1624291 MGI:1333784|MGI:3036234|MGI:97275 PMID:15601857, PMID:17940050 RGD PMID:15601857|PMID:17940050 Myocd Rat negative regulation of vascular associated smooth muscle cell migration involved_in ISO RGD:1614957 1624291 PMID:23825366 RGD PMID:23825366 Myocd Rat negative regulation of vascular associated smooth muscle cell proliferation involved_in ISO RGD:1614957 1624291 PMID:23825366 RGD PMID:23825366 Myocd Rat positive regulation of cardiac muscle cell differentiation involved_in ISO RGD:1344327 1624291 PMID:18451334 RGD PMID:18451334 Myocd Rat positive regulation of cardiac muscle hypertrophy IMP 529389387 RGD Myocd Rat positive regulation of cell population proliferation acts_upstream_of_or_within ISO RGD:1614957 1624291 PMID:11439182 RGD PMID:11439182 Myocd Rat positive regulation of DNA-templated transcription involved_in ISO RGD:1344327 1624291 PMID:19797053, PMID:31513549 RGD PMID:19797053|PMID:31513549 Myocd Rat positive regulation of DNA-templated transcription acts_upstream_of_or_within ISO RGD:1614957 1624291 PMID:15798203 RGD PMID:15798203 Myocd Rat positive regulation of epithelial to mesenchymal transition involved_in IMP 13210526 PMID:23270756 BHF-UCL Myocd Rat positive regulation of gene expression involved_in ISO RGD:1614957 1624291 PMID:23825366, PMID:24252873 RGD PMID:23825366|PMID:24252873 Myocd Rat positive regulation of miRNA transcription involved_in ISO RGD:1614957 1624291 PMID:24068960, PMID:28342807 RGD PMID:24068960|PMID:28342807 Myocd Rat positive regulation of smooth muscle cell differentiation involved_in ISO RGD:1344327 1624291 PMID:18451334 RGD PMID:18451334 Myocd Rat positive regulation of smooth muscle contraction involved_in ISO RGD:1344327 1624291 PMID:17215356 RGD PMID:17215356 Myocd Rat positive regulation of transcription by RNA polymerase II IDA 1299359 RGD Myocd Rat positive regulation of transcription by RNA polymerase II involved_in ISO RGD:1344327 1624291 PMID:14970199, PMID:15907818, PMID:17215356, PMID:19098903, PMID:19578358 RGD PMID:14970199|PMID:15907818|PMID:17215356|PMID:19098903|PMID:19578358 Myocd Rat positive regulation of transcription by RNA polymerase II acts_upstream_of_or_within ISO RGD:1614957 1624291 MGI:106658|MGI:1343094|MGI:88192 PMID:12640126, PMID:15601857, PMID:15798203, PMID:17030628, PMID:17940050, PMID:18511849, PMID:18945672, PMID:19342595 RGD PMID:12640126|PMID:15601857|PMID:15798203|PMID:17030628|PMID:17940050|PMID:18511849|PMID:18945672|PMID:19342595 Myocd Rat positive regulation of transcription by RNA polymerase II involved_in IBA FB:FBgn0052296|MGI:2137495|MGI:2384495|MGI:3050795|PANTHER:PTN008582099|RGD:631347|UniProtKB:Q8IZQ8|UniProtKB:Q969V6|UniProtKB:Q9ULH7 1600115 GO_REF:0000033 GO_Central GO_REF:0000033 Myocd Rat positive regulation of transcription by RNA polymerase II involved_in ISO RGD:1614957 1624291 PMID:19578358 RGD PMID:19578358 Myocd Rat positive regulation of transcription by RNA polymerase II involved_in IMP 401901238 PMID:19237536 UniProt Myocd Rat positive regulation of transcription by RNA polymerase II involved_in IDA 8554320 PMID:16151017 BHF-UCL Myocd Rat positive regulation of transcription by RNA polymerase II involved_in IEA ARBA:ARBA00027996 1600115 GO_REF:0000117 UniProt GO_REF:0000117 Myocd Rat positive regulation of transforming growth factor beta receptor signaling pathway involved_in ISO RGD:1614957 1624291 PMID:16224064 RGD PMID:16224064 Myocd Rat positive regulation of vascular associated smooth muscle cell migration IMP 401794130 RGD Myocd Rat regulation of cell growth by extracellular stimulus acts_upstream_of_or_within ISO RGD:1614957 1624291 PMID:11439182 RGD PMID:11439182 Myocd Rat regulation of myoblast differentiation acts_upstream_of_or_within ISO RGD:1614957 1624291 PMID:12640126 RGD PMID:12640126 Myocd Rat regulation of phenotypic switching involved_in ISO RGD:1614957 1624291 RNAcentral:URS0000527F89_10090 PMID:19578358 RGD PMID:19578358 Myocd Rat regulation of smooth muscle cell differentiation IMP 1299358 RGD Myocd Rat regulation of transcription by RNA polymerase II acts_upstream_of_or_within ISO RGD:1614957 1624291 PMID:14645532 RGD PMID:14645532 Myocd Rat response to hypoxia involved_in ISO RGD:1344327 1624291 PMID:19098903 RGD PMID:19098903 Myocd Rat response to mechanical stimulus IEP 401794130 RGD Myocd Rat response to muscle stretch IEP 401794130 RGD Myocd Rat smooth muscle cell differentiation IMP 1299359 RGD Myocd Rat smooth muscle cell differentiation acts_upstream_of_or_within ISO RGD:1614957 1624291 MGI:3052940|MGI:3773718 PMID:12867591, PMID:18188448, PMID:21357509 RGD PMID:12867591|PMID:18188448|PMID:21357509 Myocd Rat smooth muscle cell differentiation involved_in IBA MGI:2137495|MGI:3050795|PANTHER:PTN000513566|RGD:631347|UniProtKB:Q8IZQ8|UniProtKB:Q969V6 1600115 GO_REF:0000033 GO_Central GO_REF:0000033 Myocd Rat smooth muscle cell differentiation involved_in ISO RGD:1344327 1624291 PMID:14970199, PMID:15907818 RGD PMID:14970199|PMID:15907818 Myocd Rat transcription by RNA polymerase II acts_upstream_of ISO RGD:1614957 1624291 MGI:106658|MGI:88192 PMID:18511849, PMID:19342595 RGD PMID:18511849|PMID:19342595 Myocd Rat transcription initiation-coupled chromatin remodeling involved_in ISO RGD:1614957 1624291 PMID:15601857 RGD PMID:15601857 Myocd Rat transcription initiation-coupled chromatin remodeling involved_in ISS UniProtKB:Q8VIM5 1600115 GO_REF:0000024 UniProt GO_REF:0000024 Myocd Rat urinary bladder development involved_in ISO RGD:1344327 1624291 PMID:31513549 RGD PMID:31513549 Myocd Rat urinary bladder development acts_upstream_of_or_within ISO RGD:1614957 1624291 MGI:3052940 PMID:21357509 RGD PMID:21357509 Myocd Rat uterus development acts_upstream_of_or_within ISO RGD:1614957 1624291 MGI:3052940 PMID:21357509 RGD PMID:21357509 Myocd Rat vascular associated smooth muscle cell differentiation involved_in ISO RGD:1614957 1624291 RNAcentral:URS0000527F89_10090 PMID:19578358 RGD PMID:19578358 Myocd Rat vasculogenesis acts_upstream_of_or_within ISO RGD:1614957 1624291 MGI:3052940 PMID:12867591 RGD PMID:12867591 Myocd Rat ventricular cardiac muscle cell differentiation acts_upstream_of_or_within ISO RGD:1614957 1624291 MGI:3052940 PMID:21357509 RGD PMID:21357509
Molecular Function
Only show annotations with direct experimental evidence (0 objects hidden)
Myocd Rat DNA-binding transcription factor binding enables ISO RGD:1344327 1624291 UniProtKB:P52952|UniProtKB:P98177|UniProtKB:Q99801 PMID:16054032, PMID:19797053 RGD PMID:16054032|PMID:19797053 Myocd Rat histone acetyltransferase binding enables ISO RGD:1614957 1624291 PR:Q9JHD1 PMID:15601857 RGD PMID:15601857 Myocd Rat histone deacetylase binding enables ISO RGD:1614957 1624291 PR:Q9Z2V6 PMID:15601857 RGD PMID:15601857 Myocd Rat protein binding IPI RGD:1561201 10402362 RGD Myocd Rat protein binding enables ISO RGD:1614957,PR:Q8VIM5-1 1624291 UniProtKB:P10085|UniProtKB:Q04206|UniProtKB:Q04206-1|UniProtKB:Q9Y6Q9 PMID:17360478, PMID:17940050, PMID:18296632 RGD PMID:17360478|PMID:17940050|PMID:18296632 Myocd Rat protein binding enables IPI UniProtKB:A6HD62 401901238 PMID:19237536 UniProt Myocd Rat protein binding IPI RGD:1306035 401793755 RGD Myocd Rat protein binding enables ISO RGD:1344327 1624291 UniProtKB:P11831|UniProtKB:Q969V6|UniProtKB:Q9HD26 PMID:12397177, PMID:14970199, PMID:25416956, PMID:31515488 RGD PMID:12397177|PMID:14970199|PMID:25416956|PMID:31515488 Myocd Rat protein binding enables ISO RGD:1614957 1624291 PR:P13297|PR:P56581|PR:Q3TKT4|PR:Q6PCM1|PR:Q8CFN5|PR:Q9JM73|UniProtKB:B2RWS6|UniProtKB:O35295|UniProtKB:Q6NZM9|UniProtKB:Q8CFN5|UniProtKB:Q9Z2V6 PMID:11439182, PMID:15601857, PMID:16818234, PMID:17030628, PMID:17991879, PMID:18945672, PMID:19342595, PMID:33743134 RGD PMID:11439182|PMID:15601857|PMID:16818234|PMID:17030628|PMID:17991879|PMID:18945672|PMID:19342595|PMID:33743134 Myocd Rat protein binding IPI RGD:2324280 9587795 RGD Myocd Rat R-SMAD binding enables ISO RGD:1614957 1624291 UniProtKB:Q8BUN5 PMID:16224064 RGD PMID:16224064 Myocd Rat RNA polymerase II-specific DNA-binding transcription factor binding enables ISO RGD:1614957 1624291 UniProtKB:Q9JM73 PMID:11439182 RGD PMID:11439182 Myocd Rat transcription coactivator activity enables IBA FB:FBgn0052296|MGI:2137495|MGI:2384495|MGI:3050795|PANTHER:PTN008582099|UniProtKB:Q8IZQ8|UniProtKB:Q969V6|UniProtKB:Q9ULH7 1600115 GO_REF:0000033 GO_Central GO_REF:0000033 Myocd Rat transcription coactivator activity enables ISO RGD:1344327 1624291 PMID:19098903, PMID:19578358, PMID:19797053, PMID:22157009 RGD PMID:19098903|PMID:19578358|PMID:19797053|PMID:22157009 Myocd Rat transcription coactivator activity enables ISO RGD:1614957 1624291 PMID:11439182, PMID:19578358 RGD PMID:11439182|PMID:19578358
Imported Annotations - PID (archival)
1.
Islet-1 is a dual regulator of fibrogenic epithelial-to-mesenchymal transition in epicardial mesothelial cells.
Brønnum H, etal., Exp Cell Res. 2013 Feb 15;319(4):424-35. doi: 10.1016/j.yexcr.2012.12.019. Epub 2012 Dec 24.
2.
Myocardin: a component of a molecular switch for smooth muscle differentiation.
Chen J, etal., J Mol Cell Cardiol 2002 Oct;34(10):1345-56.
3.
Effects of cyclic stretch on the molecular regulation of myocardin in rat aortic vascular smooth muscle cells.
Chiu CZ, etal., J Biomed Sci. 2013 Jul 15;20(1):50. doi: 10.1186/1423-0127-20-50.
4.
HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box.
Doi H, etal., Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2328-34. Epub 2005 Sep 8.
5.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
6.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
7.
Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
Huang C, etal., Am J Physiol Heart Circ Physiol. 2019 Sep 1;317(3):H541-H551. doi: 10.1152/ajpheart.00089.2019. Epub 2019 Jul 12.
8.
Myocardin regulates BMP10 expression and is required for heart development.
Huang J, etal., J Clin Invest. 2012 Oct;122(10):3678-91. doi: 10.1172/JCI63635. Epub 2012 Sep 17.
9.
Myocardin is required for cardiomyocyte survival and maintenance of heart function.
Huang J, etal., Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18734-9. doi: 10.1073/pnas.0910749106. Epub 2009 Oct 22.
10.
Contribution of myocardin in the hypoxia-induced phenotypic switching of rat pulmonary arterial smooth muscle cells.
Jie W, etal., Exp Mol Pathol. 2010 Dec;89(3):301-6. Epub 2010 Jul 14.
11.
Enhancer of polycomb1 lessens neointima formation by potentiation of myocardin-induced smooth muscle differentiation.
Joung H, etal., Atherosclerosis. 2012 May;222(1):84-91. doi: 10.1016/j.atherosclerosis.2012.02.015. Epub 2012 Feb 18.
12.
Myocardin-related transcription factor-A induces cardiomyocyte hypertrophy.
Liao XH, etal., IUBMB Life. 2011 Jan;63(1):54-61. doi: 10.1002/iub.415.
13.
Effects of flavonoids on MicroRNA 145 regulation through Klf4 and myocardin in neointimal formation in vitro and in vivo.
Lin CM, etal., J Nutr Biochem. 2018 Feb;52:27-35. doi: 10.1016/j.jnutbio.2017.08.016. Epub 2017 Sep 14.
14.
Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin.
Liu ZP, etal., Dev Cell. 2005 Aug;9(2):261-70.
15.
Myocardin ablation in a cardiac-renal rat model.
Mittal A, etal., Sci Rep. 2019 Apr 10;9(1):5872. doi: 10.1038/s41598-019-42009-z.
16.
PID Annotation Import Pipeline
Pipeline to import Pathway Interaction Database annotations from NCI into RGD
17.
GOA pipeline
RGD automated data pipeline
18.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
19.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
20.
Comprehensive gene review and curation
RGD comprehensive gene curation
21.
Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
Shi Z, etal., Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G504-G517. doi: 10.1152/ajpgi.00302.2019. Epub 2020 Jan 13.
22.
Gene expression profiling and functional assays of activated hepatic stellate cells suggest that myocardin has a role in activation.
Shimada H, etal., Liver Int. 2010 Jan;30(1):42-54. Epub 2009 Sep 28.
23.
Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase.
Tan WQ, etal., J Biol Chem. 2008 Oct 31;283(44):29730-9. Epub 2008 Sep 4.
24.
Myocardin mRNA is augmented in the failing myocardium: expression profiling in the porcine model and human dilated cardiomyopathy.
Torrado M, etal., J Mol Med (Berl). 2003 Sep;81(9):566-77. doi: 10.1007/s00109-003-0470-7. Epub 2003 Aug 13.
25.
Myocardin is a master regulator of smooth muscle gene expression.
Wang Z, etal., Proc Natl Acad Sci U S A 2003 Jun 10;100(12):7129-34. Epub 2003 May 19.
26.
Myocardin suppression increases lipid retention and atherosclerosis via downregulation of ABCA1 in vascular smooth muscle cells.
Xia XD, etal., Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Apr;1866(4):158824. doi: 10.1016/j.bbalip.2020.158824. Epub 2020 Oct 7.
27.
CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation.
Xie P, etal., Mol Cell Biol. 2009 May;29(9):2398-408. doi: 10.1128/MCB.01737-08. Epub 2009 Feb 23.
28.
Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin.
Yoshida T, etal., Circ Res. 2004 Apr 30;94(8):1075-82. doi: 10.1161/01.RES.0000125622.46280.95. Epub 2004 Mar 11.
29.
Regulation of smooth muscle contractility by competing endogenous mRNAs in intracranial aneurysms.
Zhang M, etal., J Neuropathol Exp Neurol. 2015 May;74(5):411-24. doi: 10.1097/NEN.0000000000000185.
Myocd (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 50,332,356 - 50,426,819 (-) NCBI GRCr8 mRatBN7.2 10 49,833,219 - 49,928,806 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 49,836,641 - 49,927,627 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 54,505,304 - 54,596,319 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 53,995,291 - 54,086,296 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 49,509,995 - 49,600,991 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 51,682,053 - 51,781,458 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 51,683,540 - 51,778,986 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 51,439,727 - 51,534,567 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 51,496,223 - 51,588,226 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 51,509,851 - 51,601,849 (-) NCBI Celera 10 49,052,568 - 49,143,747 (-) NCBI Celera Cytogenetic Map 10 q24 NCBI
MYOCD (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 17 12,665,890 - 12,768,949 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 17 12,665,890 - 12,768,949 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 17 12,569,207 - 12,672,266 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 17 12,510,231 - 12,607,686 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 17 12,510,230 - 12,607,686 NCBI Celera 17 12,594,549 - 12,695,987 (+) NCBI Celera Cytogenetic Map 17 p12 NCBI HuRef 17 12,464,600 - 12,566,080 (+) NCBI HuRef CHM1_1 17 12,577,982 - 12,679,406 (+) NCBI CHM1_1 T2T-CHM13v2.0 17 12,573,362 - 12,676,444 (+) NCBI T2T-CHM13v2.0
Myocd (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 65,064,434 - 65,160,821 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 65,067,387 - 65,160,815 (-) Ensembl GRCm39 Ensembl GRCm38 11 65,173,608 - 65,269,989 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 65,176,561 - 65,269,989 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 64,990,063 - 65,083,491 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 64,992,756 - 65,086,175 (-) NCBI MGSCv36 mm8 Celera 11 72,112,506 - 72,207,425 (-) NCBI Celera Cytogenetic Map 11 B3 NCBI cM Map 11 40.42 NCBI
Myocd (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955467 4,656,380 - 4,743,110 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955467 4,653,065 - 4,743,438 (-) NCBI ChiLan1.0 ChiLan1.0
MYOCD (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 19 60,982,668 - 61,082,874 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 17 65,789,278 - 65,889,518 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 17 38,880,120 - 38,983,246 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 17 43,578,967 - 43,681,659 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 17 43,584,259 - 43,681,659 (-) Ensembl panpan1.1 panPan2
MYOCD (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 5 36,674,476 - 36,774,435 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 5 36,674,300 - 36,769,327 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 5 36,774,863 - 36,918,323 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 5 36,738,753 - 36,883,183 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 5 36,782,154 - 36,879,172 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 5 36,711,643 - 36,856,024 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 5 36,659,301 - 36,802,936 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 5 36,843,479 - 36,993,391 (+) NCBI UU_Cfam_GSD_1.0
Myocd (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405602 51,782,304 - 51,881,336 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936595 5,256,785 - 5,351,723 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936595 5,256,615 - 5,356,563 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
MYOCD (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 12 56,931,317 - 57,029,258 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 12 56,931,628 - 57,029,258 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 12 59,928,695 - 59,945,526 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
MYOCD (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 16 11,923,464 - 12,100,897 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 16 12,000,197 - 12,095,552 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666059 9,137,934 - 9,239,568 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Myocd (Heterocephalus glaber - naked mole-rat)
.
Confirmed Target Of
Mir145 rno-miR-145-5p Mirtarbase external_info qRT-PCR Functional MTI (Weak) 19542014
Predicted Target Of
Count of predictions: 236 Count of miRNA genes: 155 Interacting mature miRNAs: 189 Transcripts: ENSRNOT00000057562 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
61441 Btemp1 Thermal response to stress QTL 1 4 body temperature trait (VT:0005535) core body temperature (CMO:0001036) 10 35392457 63642539 Rat 9589136 Insul27 Insulin level QTL 27 10.46 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 10 11474010 56474010 Rat 152025229 Scl83 Serum cholesterol level QTL 83 4.33 blood cholesterol amount (VT:0000180) 10 35710580 68663659 Rat 1578779 Tcas10 Tongue tumor susceptibility QTL 10 3.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 10 31297439 76297439 Rat 152025227 Bw195 Body weight QTL 195 5.73 body mass (VT:0001259) 10 46989699 68663659 Rat 631564 Apr3 Acute phase response QTL 3 3.9 blood interleukin-6 amount (VT:0008595) plasma interleukin-6 level (CMO:0001927) 10 15275955 60275955 Rat 1298069 Bp168 Blood pressure QTL 168 5.5 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 10 26521957 98003205 Rat 2293669 Bmd33 Bone mineral density QTL 33 4.5 0.0001 femur strength trait (VT:0010010) femoral neck polar moment of inertia (CMO:0001670) 10 49444551 81709989 Rat 631552 Vetf2 Vascular elastic tissue fragility QTL 2 4.5 0.0002 aorta elastic tissue integrity trait (VT:0010556) artery internal elastic lamina non-tumorous lesion count (CMO:0001913) 10 41142633 86142633 Rat 631554 Bp133 Blood pressure QTL 133 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 743364 63851208 Rat 631557 Bp136 Blood pressure QTL 136 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 30632053 75632053 Rat 61325 Aia5 Adjuvant induced arthritis QTL 5 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1298078 Stresp5 Stress response QTL 5 2.99 0.00025 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 42045676 104670812 Rat 2293679 Bmd30 Bone mineral density QTL 30 3.5 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 10 49444551 81709989 Rat 1578761 Stresp21 Stress response QTL 21 3.3 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 10 6375746 51375746 Rat 2298544 Neuinf9 Neuroinflammation QTL 9 4.6 nervous system integrity trait (VT:0010566) spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126) 10 5801990 62146030 Rat 61463 Bp12 Blood pressure QTL 12 6.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 41333258 86333258 Rat 8694173 Bw149 Body weight QTL 149 4.38 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 10 44441699 89441699 Rat 2300218 Hpcl2 Hepatic cholesterol level QTL 2 liver cholesterol amount (VT:0010498) liver cholesterol level (CMO:0001597) 10 45029650 95600334 Rat 1554317 Bmd4 Bone mineral density QTL 4 9.4 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 19816042 99406971 Rat 1598852 Anxrr19 Anxiety related response QTL 19 5.07 body movement coordination trait (VT:0005424) number of rearing movements in an experimental apparatus (CMO:0001752) 10 18167841 63167841 Rat 1581497 Esta1 Estrogen-induced thymic atrophy QTL 1 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 10 21329805 61345413 Rat 2313095 Bss62 Bone structure and strength QTL 62 1.5 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 10 5387014 50387014 Rat 724527 Bp148 Blood pressure QTL 148 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 28453136 73453136 Rat 1358897 Stresp6 Stress response QTL 6 4.17 0.022 blood norepinephrine amount (VT:0005663) plasma norepinephrine level (CMO:0001010) 10 35392267 64155584 Rat 1331762 Rf40 Renal function QTL 40 3.873 kidney blood vessel physiology trait (VT:0100012) absolute change in renal vascular resistance (CMO:0001900) 10 29299504 64155584 Rat 2300171 Bmd58 Bone mineral density QTL 58 4.9 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 26944628 71944628 Rat 61354 Pia10 Pristane induced arthritis QTL 10 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2301967 Cm73 Cardiac mass QTL 73 4.55 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 10 14487011 89062041 Rat 2303118 Mamtr7 Mammary tumor resistance QTL 7 0.003 mammary gland integrity trait (VT:0010552) mammary tumor growth rate (CMO:0000344) 10 9658275 104670812 Rat 70188 BpQTLcluster1 Blood pressure QTL cluster 1 4.864 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 1 42323132 87323132 Rat 2313104 Bss61 Bone structure and strength QTL 61 0.9 0.0001 tibia area (VT:1000281) tibia midshaft cross-sectional area (CMO:0001717) 10 5387014 50387014 Rat 9590310 Scort19 Serum corticosterone level QTL 19 6.3 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 11474010 56474010 Rat 9589030 Epfw9 Epididymal fat weight QTL 9 19.24 0.001 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 10 44441699 89441699 Rat 10402859 Bp381 Blood pressure QTL 381 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 27606468 72606468 Rat 2316949 Gluco60 Glucose level QTL 60 3.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 14487011 107057807 Rat 2293652 Bmd22 Bone mineral density QTL 22 4.9 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 10 49444551 81709989 Rat 70198 BpQTLcluster9 Blood pressure QTL cluster 9 2.94 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 42323132 87323132 Rat 6893352 Bw100 Body weight QTL 100 0.33 0.6 body mass (VT:0001259) body weight (CMO:0000012) 1 15906665 60906665 Rat 724556 Pur2 Proteinuria QTL 2 5.5 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 10 22427500 90627625 Rat 8662860 Vetf10 Vascular elastic tissue fragility QTL 10 artery integrity trait (VT:0010639) number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562) 10 6154182 73453136 Rat 2313066 Bss63 Bone structure and strength QTL 63 1.4 0.0001 tibia strength trait (VT:1000284) bone polar moment of inertia (CMO:0001558) 10 5387014 50387014 Rat 2313064 Bmd71 Bone mineral density QTL 71 0.9 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 10 5387014 50387014 Rat 70223 Bp57 Blood pressure QTL 57 5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 1 80676123 Rat 1354587 Kidm21 Kidney mass QTL 21 3.3 kidney mass (VT:0002707) right kidney wet weight (CMO:0000082) 10 15028513 60430477 Rat 6893350 Bw99 Body weight QTL 99 0.87 0.16 body mass (VT:0001259) body weight (CMO:0000012) 1 15906665 60906665 Rat 2317043 Aia7 Adjuvant induced arthritis QTL 7 3.82 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 10 37565079 82565079 Rat 70224 Eae3 Experimental allergic encephalomyelitis QTL 3 4.1 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 10 26521957 61345413 Rat 2317042 Aia20 Adjuvant induced arthritis QTL 20 3.38 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 10 37565079 82565079 Rat 2313081 Bss64 Bone structure and strength QTL 64 1.3 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 10 5387014 50387014 Rat 1331791 Cm31 Cardiac mass QTL 31 3.84606 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 29299504 107211142 Rat 2313087 Bmd80 Bone mineral density QTL 80 3.2 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 10 19606483 64606483 Rat 1354614 Hpcl1 Hepatic cholesterol level QTL 1 3.3 liver cholesterol amount (VT:0010498) liver cholesterol level (CMO:0001597) 10 35392267 51793994 Rat 631532 Cm50 Cardiac mass QTL 50 6.6 heart mass (VT:0007028) calculated heart weight (CMO:0000073) 10 17907113 51786432 Rat 1576319 Cia29 Collagen induced arthritis QTL 29 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 33973921 78973921 Rat 8552805 Bw145 Body weight QTL 145 2.2 body mass (VT:0001259) change in body weight to body weight ratio (CMO:0002216) 10 41944526 78307017 Rat 631267 Cia20 Collagen induced arthritis QTL 20 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1600371 Mcs21 Mammary carcinoma susceptibility QTL 21 3 mammary gland integrity trait (VT:0010552) mammary tumor growth rate (CMO:0000344) 10 28875650 52200160 Rat 2293705 Bmd25 Bone mineral density QTL 25 7.1 0.0001 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 10 49444551 81709989 Rat 1576308 Schws1 Schwannoma susceptibility QTL 1 0.0041 nervous system integrity trait (VT:0010566) percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) 10 40035094 102359817 Rat 631269 Cia22 Collagen induced arthritis QTL 22 8.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 631268 Cia21 Collagen induced arthritis QTL 21 3.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 14487011 104060283 Rat 9590268 Scort13 Serum corticosterone level QTL 13 3.26 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 11474010 56474010 Rat 7207811 Bmd90 Bone mineral density QTL 90 5.2 femur size trait (VT:1000369) femoral neck cross-sectional area (CMO:0001697) 10 49444551 81709989 Rat 1576311 Pia26 Pristane induced arthritis QTL 26 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 31224026 75632053 Rat 631270 Cia23 Collagen induced arthritis QTL 23 3.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 7411614 Foco18 Food consumption QTL 18 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 10 44441699 89441699 Rat 631547 Bp87 Blood pressure QTL 87 4.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 47369470 92369470 Rat 61427 Cia16 Collagen induced arthritis QTL 16 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 6357896 96121100 Rat 6893342 Cm78 Cardiac mass QTL 78 0.1 0.88 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 10 42876766 79813922 Rat 2292441 Bp308 Blood pressure QTL 308 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 27606468 72606468 Rat 2313055 Bw96 Body weight QTL 96 3.6 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 10 19606483 64606483 Rat 631542 Bp82 Blood pressure QTL 82 6.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 26521957 98952741 Rat
D10Rat62
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 49,900,287 - 49,900,435 (+) MAPPER mRatBN7.2 Rnor_6.0 10 51,747,009 - 51,747,156 NCBI Rnor6.0 Rnor_5.0 10 51,503,287 - 51,503,434 UniSTS Rnor5.0 RGSC_v3.4 10 51,560,410 - 51,560,558 RGD RGSC3.4 RGSC_v3.4 10 51,560,411 - 51,560,558 UniSTS RGSC3.4 RGSC_v3.1 10 51,574,034 - 51,574,181 RGD Celera 10 49,116,392 - 49,116,539 UniSTS RH 3.4 Map 10 581.0 UniSTS RH 3.4 Map 10 581.0 RGD RH 2.0 Map 10 568.7 RGD FHH x ACI Map 10 40.36 RGD Cytogenetic Map 10 q24 UniSTS
RH133589
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 49,907,920 - 49,908,113 (+) MAPPER mRatBN7.2 Rnor_6.0 10 51,758,961 - 51,759,153 NCBI Rnor6.0 Rnor_5.0 10 51,514,423 - 51,514,615 UniSTS Rnor5.0 RGSC_v3.4 10 51,568,519 - 51,568,711 UniSTS RGSC3.4 Celera 10 49,124,042 - 49,124,234 UniSTS RH 3.4 Map 10 580.3 UniSTS Cytogenetic Map 10 q24 UniSTS
PMC150745P1
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 10 50,348,690 - 50,348,798 (+) Marker Load Pipeline mRatBN7.2 10 49,849,554 - 49,849,663 (+) MAPPER mRatBN7.2 Rnor_6.0 10 51,696,454 - 51,696,562 NCBI Rnor6.0 Rnor_5.0 10 51,452,647 - 51,452,755 UniSTS Rnor5.0 RGSC_v3.4 10 51,509,143 - 51,509,251 UniSTS RGSC3.4 Celera 10 49,065,353 - 49,065,461 UniSTS Cytogenetic Map 10 q24 UniSTS
PMC309615P1
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 49,849,919 - 49,850,213 (+) MAPPER mRatBN7.2 Rnor_6.0 10 51,696,819 - 51,697,112 NCBI Rnor6.0 Rnor_5.0 10 51,453,012 - 51,453,305 UniSTS Rnor5.0 RGSC_v3.4 10 51,509,508 - 51,509,801 UniSTS RGSC3.4 Celera 10 49,065,718 - 49,066,011 UniSTS Cytogenetic Map 10 q24 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
112
74
73
42
25
42
6
200
97
92
44
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000057562 ⟹ ENSRNOP00000054372
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 49,836,641 - 49,927,627 (-) Ensembl Rnor_6.0 Ensembl 10 51,683,540 - 51,778,986 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000078675 ⟹ ENSRNOP00000072988
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 49,836,641 - 49,927,627 (-) Ensembl Rnor_6.0 Ensembl 10 51,685,228 - 51,778,939 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000109338 ⟹ ENSRNOP00000084177
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 49,836,641 - 49,892,157 (-) Ensembl
RefSeq Acc Id:
NM_001414232 ⟹ NP_001401161
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 50,332,356 - 50,426,819 (-) NCBI mRatBN7.2 10 49,833,219 - 49,927,682 (-) NCBI
RefSeq Acc Id:
NM_182667 ⟹ NP_872608
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 50,332,356 - 50,426,819 (-) NCBI mRatBN7.2 10 49,833,219 - 49,927,682 (-) NCBI Rnor_6.0 10 51,683,534 - 51,778,986 (-) NCBI Rnor_5.0 10 51,439,727 - 51,534,567 (-) NCBI RGSC_v3.4 10 51,496,223 - 51,588,226 (-) RGD Celera 10 49,052,568 - 49,143,747 (-) RGD
Sequence:
GCCACCCTCAGAGGAGGAGGGTCCTGCCTGCTGGGAGTTAATTAGCCTCGCAAGCGGCGAGGGGGGAGGCGCCAGTTTTCTGGGGACACTGGCGGCCACTGTGTGTCCTCCTGCCCAAGGGAGCTCCC CAAGAGTTGGATGAATTCTGGGTCGTTAGCTGCTGTCCTCTGGGCTCCCTGGAGCCAATTTCTGGTGGAAAGCGGGGCGTCTGGCCAGCGACCAGCGGCTTGCTGAGACTCACCATGACACTCCTGGG GTCTGAACACTCTTTGCTGATTAGAAGGAAGTTCCGATCAGTCTTACAGTTACGGCTTCAACAGAGAAGGACCCAGGAGCAGCTGGCTAACCAAGGCTTAATACCACCCCTGAAAAGTCCAACTGAGT TCCATGACCCGAGGAAAAAACTGGATAGTGCCAAGACTGAAGACTCTCTGAGGCGCAAGGTCAGAAACAGATCGGACCGTGCCAGCCTGGTTAATATGCACATTCTCCAAGCCTCCACGGCAGAAAGA TCCATTCCAACTGCTCAGATGAAGCTGAAGAGAGCCCGCCTTGCAGATGACCTCAACGAGAAGATTGCTCTCCGCCCAGGGCCCTTGGAACTGGTGGAGAAGAACATTCTGCCTATGGATTCTTCCGT GAAAGAGGCTATAAAAGGTACTGAGGTGAGCCTCTCCAAAGCAGCAGATGCATTTGCCTTTGAAGATGACAGCAGCAGGGATGGGCTTTCCCCAGATCAGGCTCGGAGCGAGGATCCCCAGGGCTCTG GAGGATCAACCCCAGACATCAAATCCACTGAGGCTCCTCTGGCTGGCCCTCTGGACACAATCCAGGATCTCACTCCTGGCTCAGAAAGTGACAAGAACGATACAGCCTCCCAGCTGAGCAACCAGTCA GACTCTGGGAAGCAGGTGCTTGGCCCTCTCAGCACCCCGATCCCTGTGCACACTGCGGTAAAGTCCAAGTCTTTGGGTGATAGTAAGAACCGCCACAAAAAGCCCAAAGACCCCAAACCAAAGGTGAA GAAGCTCAAATACCACCAGTACATCCCCCCGGACCAGAAGGCAGAGAAATCCCCTCCCCCCATGGACTCTGCCTATGCTCGGCTGCTTCAGCAACAGCAGCTATTCCTGCAGCTACAGATCCTCAGCC AGCAGCAACAGCAGCAGCAACAGCAGCAACAGCAGCAGCAGCAACAGCAGCAACAGCAACGGTTCAGCTACCCTGGGATGCACCAAGCACACCTCAAAGAGCCAAATGAACAGATGACCAGAAATCCG AATTCTTCCTCAACACCACTGAACAATACCCCGCTGTCCCCTGTCAAAAATAGCCTTTCTGGACAAACTGGTGTTTCTTCTCTCAAACCAGGCCCCCTTCCACCAAACCTGGATGATCTCAAGGTGTC AGAGTTAAGACAACAGCTTCGAATCCGGGGCTTGCCAGTGTCGGGCACCAAGACAGCACTGGTGGACCGGCTTCGACCCTTCCAGGATTGTGCTGGCAACCCTGTGCCCAACTTTGGGGACATCACAA CTGTCACCTTTCCTGTCACGCCCAACACCTTGCCCAGTTATCAGTCCTCCCCATCAGGCTTCTACCACTTTGGCAGCACAAGCTCCAGCCCGCCCATCTCCCCCGCCTCATCTGACTTGTCTGCTGCA GGGTCCCTGCCAGACACCTTCACCGATGCGTCACCTGGCTTCGGCCTGCATGCATCGCCGGTGCCCGCCTGTACGGATGAGAGTCTGCTGAGCAGCCTGAATGGGGGCTCGGGCCCCTCCGAGCCTGA CGGGCTAGACTCTGAGAAGGACAAGATGCTGGTAGAGAAGCAAAAGGTGATCAACCAGCTCACCTGGAAGCTGCGGCAAGAGCAGCGGCAGGTGGAGGAGCTGAGAATGCAACTGCAGAAGCAGAAGA GCGGCTGCAATGACCAGAAGCCACTGCCCTTCTTGGCCACCACCATCAAGCAGGAAGATGTCTCTAGCTGTCCCTTCGCAGCCCAGCAGGCATCTGGGAAGGGACAGGGCCACAGCTCCGACAGTCCC CCTCCGGCCTGTGAGACTGCTCAGCTGCTGCCTCACTGTGTGGAGTCCTCAGGTCAAACCCATGTACTCTCCTCCACATTTCTCAGCCCCCAGTGCTCCCCTCAGCACTCCCCCCTGGGGACCCTGAA GAGCCCGCAACACATCAGCCTGCCCCCATCGCCTAACAACCATTACTTCCTGGCTTCCTCCTCTGGGGCTCAGAGAGAGAACCATGGGGTGTCTTCACCCAACAGCAGCCAAGGGTGTGCACAGATGA CTGGTTTACAATCTTCTGACAAGGTGGGGCCAACGTTTTCAATTCCATCCCCAACTTTTCCTAAGTCGAGTCCAACAGTTCCGGAGATAACCCAGCCCCCATCCTACGAAGATGCAGTGAAACAGCAA ATGACTCGGAGTCAGCAGATGGATGAACTCCTGGATGTCCTCATTGAAAGTGGAGAAATGCCAGCGGATGCCAGGGAAGATCATTCATGTCTTCAAAAAATCCCAAAGATACCTGGGTCCTCCTGCAG CCCAACCACCATCCTCCCCAAGTCCTCGGCTTCCTTTGAACAGGCATCTTCGGGAGGCCAGATCTCCTTCGATCACTATGCCACCGACAGTGAGGAACACCTGGAAGTCTTATTGAATTCTCACAGCC CCATTGGGAAGGTGAGCGATGTTACCCTCCTCAAAATCGGAAGCGAGGAGCCTCCTTTTGATGGGATCATGGATGGCTTCCCAGGGAAGGCTGCGGAAGATCTCTTCAGTGCTCATGAGCTCTTGCCT GGGCCGCTCTCCCCTATGCATACACAGTTGTCACCTCCTTCTGTGGACAGCAGTGGTCTGCAGCTGAGCTTCACGGAATCTCCTTGGGAAACAATGGAATGGCTGGACCTCACTCCACCTAGTTCCAC ACCAGGCTTCAGCAACCTCACCTCCAGCGGGCCCAGCATTTTCAACATCGATTTTCTGGATGTCACGGATCTCAATTTGAATTCCCCTATGGACCTCCACTTACAGCAGTGGTAAACACCTGAGGTAC AAGTGTTATGAGAGCTCAGTAGGAATTCCATGGGGGAGAGCACACAACCAGAAATGTGTGATCCAAAAGATAAAGGGGAGAAAAATGGGGAGAAAAAAAAACGGGATGGAGGTTTCTGTGACAATCAA CCGGAACAGGAGTCAGTCATTAAAATATGTGTAATGTAATATCAATAACTGTTAATAACTTCGGTGATGCATTCGAAATGTGCCTTGTTGGAGTAAGAGTGCCAAAGATGTCTTTTTCACCGCCTTAG CTCATACCAGTACCTTTTTAGCCCACAGTCTGTCTCAGGCATTACTGGGACGTAAGTTCACACTATATAGTCTGTCTCAGGCATTATCGGGACATAGACTGACACCATTAGCTTTTGTTATGAATTTA CTACACTTTCTGTGCAAGGAGAAAAACTCCTCCTCAAGGAGCACAGGGAAGTCCCTCAACTATTCCGGAAGCCATCCTATGCCTGAGGCAACCCCATCCCGCCCCCTCCCCACACACCTGTGTGTCCT TCTAACTTTCAGAAGAGCAGGGCCTATTTCAGCCAATAGAGTTCTTAAGGCAGAATAATCAGAATGGTCAGAGGGACAGACCAATCAATTCCCAGGAGAGCAACTCAGTGTCCCTCAACCCCCGAATG GTCCCACTGGACTGGCGATCACTGGCGACAACTAACTAGCATTATCCAGAAATCCACCCAGAACACGGTGCTTTTTAGCCAGTAGACCAGTTTTTTTTTTTCTGCTACCTCTATGCTCATCAGTGATG CATAGCAGGTGAGAAACTTGAATCACAACAACTTCATGCTGTGGATGGAGACTCCTGAGGCTCTCAAATGCTACCACCTCTAGTTCCATAGACCAGAGATAGATGATCAGAAAGGCAACTGGAGGCCC AGGGAGCCGTACTGGGACAAGTAGAATTGGAGAAAATGCCATTTAACATTCCGGGAAAGAAATACCATGGATTGCTATTACATGAGCAACACACAGGGCCAACTTCCTTTTCTTCTTCTTTATCTTTC TTTTCTTATTGTAGACAGAGGGAATTCACCTCAGTTTATTTTCCTCTCAGTACTTTTATTTCAAGATATTAATTCTTTATGATTCTTTTGCTTTTGATTCTCTCTCTCTCTCTCTCTCTCTCTCTCTC TCTCTCTCTCTTACTCTCCCTCTCTTGGAAAGGAGAGGTTTCAGCTCTAACAAGCTACCGTATTCCTATTAAAGCCACTTTTTTAGAACATTAAAGTCCAAACTCTCTTGCTAAACTCGTTCTTCACA TGCACATTGACTGCAAACAGAATTCATAAGAATTCCCTTAGGAAGAAACTGGGGAAGTGGCCCATTGGTCACAAAGTTCTTTTTTTTTTTTAACTCTTGTTTGATTTAAGGATAATCTTTGGTTTGTG TTACTCTGGAGACATTGGAAATCATTAGAGAGTGAAGATAAATCAGGGGGCCATGTAAAGTAGAGAATGTGTCAGTCAGTTTTCCAAATGAGAGCACAATTGCACACCATAAACAACATGAGAGTGAA GGATCAGAGTCTTGGGGAGTTTTTCTTGTTGCCCTGTGTTTGGTCAGGGCACTGGGGACTGAGGAAGACAACACAGATTGCCCGAGTCTCTCAGAGGCTACTGTGGCACCAATTCAAGTATTACAATG TTGCATGCTGTAGAAAGTAGCTGTTGCTGTTTTTTGTTTTGTCTTGTTTCGTTTTGTTTTAATTTAAGTCACCAAGGCACTGTTTTATTCTTTTGTAAAAAAAATTCACTGTGCACTTATAGAGAAAA TAATCAACAATGTTGTGAATTTTTGAGAAGTTGTCTTTTTTGATAAACCAAAGATTTAGAAATCATTCCATTGTCAACTTGTAAAAAA
hide sequence
RefSeq Acc Id:
XM_006246583 ⟹ XP_006246645
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 50,332,502 - 50,426,534 (-) NCBI mRatBN7.2 10 49,833,219 - 49,928,806 (-) NCBI Rnor_6.0 10 51,682,053 - 51,781,458 (-) NCBI Rnor_5.0 10 51,439,727 - 51,534,567 (-) NCBI
Sequence:
GAGAAGGAAGAAGGGGAGGAAGAGGAGGAGGAAGAAGAAGAAAAAGGAGACCACAAGGACAGCTCAGAGGTAGATGGATAGGGAGGCAAGGAAGGTGGAGAGAGGAGATCTGAATTGGGTTGAGGGAG GGATTGTGAATATGATCCAAATTTATTATATGAAATTCTTGAAGAATTACTTAAAATATTAGTTTAAGGATTAATGAGATGAAAACTAAAAGAATCACAGGGCAGGGAGACCTCTTCTCACTAAACAA CAGTAAAAGAAAGCAAGCAAAAGAGGGACTATGGTCTTGTCCACAAGCACAAACTCAAACACCCTCCCTCCCTCTGGGTCAGGAAGACCCTTGGTTGGATTCTTCAGTTGATTTTTATCACACCTCCC ACTAAACAAAGAATGCCCTCGCTAAGCTGTCTTGGGCATCTTTTTATGCTGTCCTCAGTGTAAAAGTCAGTTTGGGTCTTTCCTTCAATTCTTTCTTCTTCGTGTTTCATGGAGTAGTTTTCTCCCTG GGATAATTTTGTGATGTCCCTTACACCTCTTTTCTCTGGAGTAACCCTTGCCACATGCATCCCAAGCCTGCTTAGGGCTCTTCTAGACATGCGGGCCTGTTCCCTCCCACCCGCCTCTGTTTTGTTTC TTTTCATCAACGAATTGGATTGTGGGATTTAAGTACAACAAAGAGAAGCTGGGCAGGGAGACAGTCTCTATGTAGCCCATAATATAACATCTTCCCCTTCGCCTCCTAAGTTCAGGCATTTGCGATTA TGTTACCCTGCGTAGCAAGTGGGAATTAAGACTCATAATCAGCCAGCCTGACAGTTTTTTCCTTAACGTAAGGTTAAATCGGAGAGAGATGCAGAAGGTGGGGAGGGAGTCGCTAGACTGATAAGACG TAATAAGAACTTGACCCACAATTTCTGTTTTGGAGGATGGAAGAACAGGCTGGAAGCCAAGGAACATGGGTGGCCTCTAGTAGCTGGAAAGGGAAAGGAAATGGATTCTCTTCATGAGCTTCCAGGAG GGAACACAGCTCTGCCAACACCTTGATTTTTAACCCAGTGAGACCTGTTTCTGACTCCCAGCCTTCCAACCTGCACAGTAATGAGTCCAGACTGATGTGAGCCGTTAGAGCAGTTGTGGCAAGTTCCC ACAGGAACAGCCCAGTTCAACACTGCTTGTGGAATGCACAGCCACTGCCAGGCTACCACAGGAGGCAGCATGTCGCAGGCCTGTGCTGCTGCCCAACCCTATTCACAAGAGGAAGTTGTGTAGAAGGG TTCCGCCTCCTCTCTGATTCAGTGAGGAAGAACATTACCTATTCCAGAAAACTTTGATTCTGGGATTCAAGTGCATTTGGTGCAACCCAGAGGAGGAGGAAAAGGAAGGTCTGGGTCTTCAGCAACAG ATGATGGAGGCAGAAGACCCCGGGATCAGGGCAGAGACTAGCCCCAAAAGATATTGTTATTTTAGGCCTCCACCTGTCCTGGGCTGATCCGTTCAAGAATTCACAGCTTTGAAGCAAAAGCAAAGAGG TAAAGAATTGTACTTGGGAGCCCACGTGCATATAAAGTTGAAAATGGTGGCAAATCGTGTGTTGTGTGTATGCAGTTCAGTTTTTTTAAATATCTAAGTCTTCGTCTTAGATGGAATATTTGTTGTAC TTAATGACGCACATGGCACCCTGTCGCCCCAGGCGCCCCTGAGACATGCATCATCAGCGCCGCTTTGAGTGCCCGGTGGATTTCCCACGATTAAGCGGGATGTGAAAAATCTCTGTGCCTTTCCAATC TGGCTCGCCCAGGCCACCGAGTGCGACCCTGCTGAGCACCCAATAGTACACTCAACTTTTGCACACACTCCCCCTCCGGGCTTGGTCCCCAGCCACAAACTTTGTGTGTCCCCAAAGAGAGCATCCAA CCACAGCGAAAGACTTTTTGCCACCTCCTCGGACGCTCATAGACAGCGATAGCTGCTCCAGGCATCCATCTCCTGAAGCACCACCGCTCGGATGCAGAGGGAAAGCGGGTGCTCCCGGGAATTGCAAG CCGACCCTACTTCTTGGCTCAGGCTCCAGCGCGTTCCGAGGATGTGCCTTCCCGAGCAGTCCCAGTAGGCTGGGGACACTGGGGACATTCACACCTACGGCAAGCGGATACGCTCCTACCGTCGCCGG GCGCCACCTGCAGCCTTCGAGCATCCGGTTTAGGGGTGTCAGTGCAGAGACTCCCGCCTGGGCAAGCAGTCTTGGCTTAGTATTCTGCAAAGAGTTAAGAGCCTGCTGTTGAGGCTCCTGGGGCCGCG CCTGGTCCCCAGGCCCCGCTCGCCTCTCCTGATTGGCTGGTTTCCTGTCAGTAGTAAAGAGGATCAGATAGCAAACTTGGGACCTTCATAAAGGCGTGGTGGCGATACTCCGCGACCGCTGGCAGCCT ATGACATCAGTCAGGAACGCCTAGGATGCGGCTGTTCCTGGCCACCCTCAGAGGAGGAGGGTCCTGCCTGCTGGGAGTTAATTAGCCTCGCAAGCGGCGAGGGGGGAGGCGCCAGTTTTCTGGGGACA CTGGCGGCCACTGTGTGTCCTCCTGCCCAAGGGAGCTCCCCAAGAGTTGGATGAATTCTGGGTCGTTAGCTGCTGTCCTCTGGGCTCCCTGGAGCCAATTTCTGGTGGAAAGCGGGGCGTCTGGCCAG CGACCAGCGGCTTGCTGAGACTCACCATGACACTCCTGGGGTCTGAACACTCTTTGCTGATTAGAAGGAAGTTCCGATCAGTCTTACAGTTACGGCTTCAACAGAGAAGGACCCAGGAGCAGCTGGCT AACCAAGGCTTAATACCACACTAATCCAAGCTACATCAGCCACATACTTACTGCAAAGCCTTGCCCTGAAAAGTCCAACTGAGTTCCATGACCCGAGGAAAAAACTGGATAGTGCCAAGACTGAAGAC TCTCTGAGGCGCAAGGTCAGAAACAGATCGGACCGTGCCAGCCTGGTTAATATGCACATTCTCCAAGCCTCCACGGCAGAAAGATCCATTCCAACTGCTCAGATGAAGCTGAAGAGAGCCCGCCTTGC AGATGACCTCAACGAGAAGATTGCTCTCCGCCCAGGGCCCTTGGAACTGGTGGAGAAGAACATTCTGCCTATGGATTCTTCCGTGAAAGAGGCTATAAAAGGTACTGAGGTGAGCCTCTCCAAAGCAG CAGATGCATTTGCCTTTGAAGATGACAGCAGCAGGGATGGGCTTTCCCCAGATCAGGCTCGGAGCGAGGATCCCCAGGGCTCTGGAGGATCAACCCCAGACATCAAATCCACTGAGGCTCCTCTGGCT GGCCCTCTGGACACAATCCAGGATCTCACTCCTGGCTCAGAAAGTGACAAGAACGATACAGCCTCCCAGCTGAGCAACCAGTCAGACTCTGGGAAGCAGGTGCTTGGCCCTCTCAGCACCCCGATCCC TGTGCACACTGCGGTAAAGTCCAAGTCTTTGGGTGATAGTAAGAACCGCCACAAAAAGCCCAAAGACCCCAAACCAAAGGTGAAGAAGCTCAAATACCACCAGTACATCCCCCCGGACCAGAAGGCAG AGAAATCCCCTCCCCCCATGGACTCTGCCTATGCTCGGCTGCTTCAGCAACAGCAGCTATTCCTGCAGCTACAGATCCTCAGCCAGCAGCAACAGCAGCAGCAACAGCAGCAACAGCAGCAGCAGCAA CAGCAGCAACAGCAACGGTTCAGCTACCCTGGGATGCACCAAGCACACCTCAAAGAGCCAAATGAACAGATGACCAGAAATCCGAATTCTTCCTCAACACCACTGAACAATACCCCGCTGTCCCCTGT CAAAAATAGCCTTTCTGGACAAACTGGTGTTTCTTCTCTCAAACCAGGCCCCCTTCCACCAAACCTGGATGATCTCAAGGTGTCAGAGTTAAGACAACAGCTTCGAATCCGGGGCTTGCCAGTGTCGG GCACCAAGACAGCACTGGTGGACCGGCTTCGACCCTTCCAGGATTGTGCTGGCAACCCTGTGCCCAACTTTGGGGACATCACAACTGTCACCTTTCCTGTCACGCCCAACACCTTGCCCAGTTATCAG TCCTCCCCATCAGGCTTCTACCACTTTGGCAGCACAAGCTCCAGCCCGCCCATCTCCCCCGCCTCATCTGACTTGTCTGCTGCAGGGTCCCTGCCAGACACCTTCACCGATGCGTCACCTGGCTTCGG CCTGCATGCATCGCCGGTGCCCGCCTGTACGGATGAGAGTCTGCTGAGCAGCCTGAATGGGGGCTCGGGCCCCTCCGAGCCTGACGGGCTAGACTCTGAGAAGGACAAGATGCTGGTAGAGAAGCAAA AGGTGATCAACCAGCTCACCTGGAAGCTGCGGCAAGAGCAGCGGCAGGTGGAGGAGCTGAGAATGCAACTGCAGAAGCAGAAGAGCGGCTGCAATGACCAGAAGCCACTGCCCTTCTTGGCCACCACC ATCAAGCAGGAAGATGTCTCTAGCTGTCCCTTCGCAGCCCAGCAGGCATCTGGGAAGGGACAGGGCCACAGCTCCGACAGTCCCCCTCCGGCCTGTGAGACTGCTCAGCTGCTGCCTCACTGTGTGGA GTCCTCAGGTCAAACCCATGTACTCTCCTCCACATTTCTCAGCCCCCAGTGCTCCCCTCAGCACTCCCCCCTGGGGACCCTGAAGAGCCCGCAACACATCAGCCTGCCCCCATCGCCTAACAACCATT ACTTCCTGGCTTCCTCCTCTGGGGCTCAGAGAGAGAACCATGGGGTGTCTTCACCCAACAGCAGCCAAGGGTGTGCACAGAACTCAGGGGCACATGAAGGTCATCCTCCTAGCTTCTCTCCCCCATCT TCCAGCCTCCATCAGCCTTTCTCTGGCACCCAAGCAGACAGCAGTCACAGTTCTGGGCTCAACCCTTGTCCCAAAAGCCCAGTTATTCATCCAAAGATGACTGGTTTACAATCTTCTGACAAGGTGGG GCCAACGTTTTCAATTCCATCCCCAACTTTTCCTAAGTCGAGTCCAACAGTTCCGGAGATAACCCAGCCCCCATCCTACGAAGATGCAGTGAAACAGCAAATGACTCGGAGTCAGCAGATGGATGAAC TCCTGGATGTCCTCATTGAAAGTGGAGAAATGCCAGCGGATGCCAGGGAAGATCATTCATGTCTTCAAAAAATCCCAAAGATACCTGGGTCCTCCTGCAGCCCAACCACCATCCTCCCCAAGTCCTCG GCTTCCTTTGAACAGGCATCTTCGGGAGGCCAGATCTCCTTCGATCACTATGCCACCGACAGTGAGGAACACCTGGAAGTCTTATTGAATTCTCACAGCCCCATTGGGAAGGTGAGCGATGTTACCCT CCTCAAAATCGGAAGCGAGGAGCCTCCTTTTGATGGGATCATGGATGGCTTCCCAGGGAAGGCTGCGGAAGATCTCTTCAGTGCTCATGAGCTCTTGCCTGGGCCGCTCTCCCCTATGCATACACAGT TGTCACCTCCTTCTGTGGACAGCAGTGGTCTGCAGCTGAGCTTCACGGAATCTCCTTGGGAAACAATGGAATGGCTGGACCTCACTCCACCTAGTTCCACACCAGGCTTCAGCAACCTCACCTCCAGC GGGCCCAGCATTTTCAACATCGATTTTCTGGATGTCACGGATCTCAATTTGAATTCCCCTATGGACCTCCACTTACAGCAGTGGTAAACACCTGAGGTACAAGTGTTATGAGAGCTCAGTAGGAATTC CATGGGGGAGAGCACACAACCAGAAATGTGTGATCCAAAAGATAAAGGGGAGAAAAATGGGGAGAAAAAAAAACGGGATGGAGGTTTCTGTGACAATCAACCGGAACAGGAGTCAGTCATTAAAATAT GTGTAATGTAATATCAATAACTGTTAATAACTTCGGTGATGCATTCGAAATGTGCCTTGTTGGAGTAAGAGTGCCAAAGATGTCTTTTTCACCGCCTTAGCTCATACCAGTACCTTTTTAGCCCACAG TCTGTCTCAGGCATTACTGGGACGTAAGTTCACACTATATAGTCTGTCTCAGGCATTATCGGGACATAGACTGACACCATTAGCTTTTGTTATGAATTTACTAAACTTTCTGTGCAAGGAGAACAAAT CCTCCTCAAGGAGCACAGGGAAGTCCCTCAACTATTCCGGAAGCCATCCTATGCCTGAGGCAACCCCATCCCGCCCCCTCCCCACACACCTGTGTGTCCTTCTAACTTTCAGAAGAGCAGGGCCTATT TCAGCCAATAGAGTTCTTAAGGCAGAATAATCAGAATGGTCAGAGGGACAGACCAATCAATTCCCAGGAGAGCAACTCAGTGTCCCTCAACCCCCGAATGGTCCCACTGGACTGGCGATCACTGGCGA CAACTAACTAGCATTATCCAGAAATCCACCCAGAACACGGTGCTTTTTAGCCAGTAGACCAGTTTTTTTTTTTCTGCTACCTCTATGCTCATCAGTGATGCATAGCAGGTGAGAAACTTGAATCACAA CAACTTCATGCTGTGGATGGAGACTCCTGAGGCTCTCAAATGCTACCACCTCTAGTTCCATAGACCAGAGATAGATGATCAGAAAGGCAACTGGAGGCCCAGGGAGCCGTACTGGGACAAGTAGAATT GGAGAAAATGCCATTTAACATTCCGGGAAAGAAATACCATGGATTGCTATTACATGAGCAACACACAGGGCCAACTTCCTTTTCTTCTTCTTTATCTTTCTTTTCTTATTGTAGACAGAGGGAATTCA CCTCAGTTTATTTTCCTCTCAGTACTTTTATTTCAAGATATTAATTCTTTATGATTCTTTTGCTTTTGATTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTTACTCTCCCTCTCTTGG AAAGGAGAGGTTTCAGCTCTAACAAGCTACCGTATTCCTATTAAAGCCACTTTTTTAGAACATTAAAGTCCAAACTCTCTTGCTAAACTCGTTCTTCACATGCACATTGACTGCAAACAGAATTCATA AGAATTCCCTTAGGAAGAAACTGGGGAAGTGGCCCATTGGTCACAAAGTTCTTTTTTTTTTTTAACTCTTGTTTGATTTAAGGATAATCTTTGGTTTGTGTTACTCTGGAGACATTGGAAATCATTAG AGAGTGAAGATAAATCAGGGGGCCATGTAAAGTAGAGAATGTGTCAGTCAGTTTTCCAAATGAGAGCACAATTGCACACCATAAACAACATGAGAGTGAAGGATCAGAGTCTTGGGGAGTTTTTCTTG TTGCCCTGTGTTTGGTCAGGGCACTGGGGACTGAGGAAGACAACACAGATTGCCCGAGTCTCTCAGAGGCTACTGTGGCACCAATTCAAGTATTACAATGTTGCATGCTGTAGAAAGTAGCTGTTGCT GTTTTTTGTTTTGTTTTGTTTCGTTTTGTTTTAATTTAAGTCACCAAGGCACTGTTTTATTCTTTTGTAAAAAAAATTCACTGTGCACTTATAGAGAAAATAATCAACAATGTTGTGAATTTTTGAGA AGTTGTCTTTTTTGATAAACCAAAGATTTAGAAATCATTCCATTGTCAACTTGTAAAAAAAAAAAAAGTTTGATCACTGAGTGTTTTTTGGTGACTGCTACTCTGGAAGCCACCAGATCTTATTGTAG GGAAGGAAACACAGATATGCACACATATGTAGTTCTATGCCTGTGTGTATGGGGTATGTGTATGCATACATGCACATGTGTATACAACTGTGTGTGTGCACGCATATCTGAAAGGTGGCATTCAGAGG GCCTCAAACCCTCAGTCCGCTGTGAATGATGTGTGGCCTTTCTCACTATAAGTTGCTGATTGATCAACAAGACTCCACGTTGCCTCTCTGTATGTGACTAAAGACTCCAACCCAATGCCCATAGCCAC TTGCTGCAAGTGAACAAGCTCCTCCTGGCAATGAATATGGATTTGAGAGGATCAAGCCTGGCAGTGAATTCGGACACGATAGGACAGAGTGGCTTCATCATCAGTAGCTGCTAAGGCTAGTGCCTTCT CTTACAGAAGAGTCTAAAGGGAGCACGAAACTTGTTCTGACATTCCTTGATCTGCAATGCGCTTGAAAGGGTCTGCGTGATAAACTTCTCATTGTGTTTGTTGCAACCGGAACCACAGATCCAGAGGC AAAGCTTAGCATGAAGATGAAGCTGGGGGAAGGAACCTTATTACCACATTCCAAACATTGCCCTCCGAGGCTGATGTTTCATTTGAGTCTGGATGAAGCTTCCTGCTCTTTTTTAGGCTTTGGATGAA CCATGTATGCTATTCCCTCCTTGCTTCTTTGGAAAACAAATCCATACAGTGTCCTGCCTCCGAGACCCTCATCTGAGTGCTAATAATTTTCCCTTTGGGAATTCCTGTCAGGGCGATTGGTTAGACAG CTCTGTTTTTTTTTTTTTTCCAGCTAGACTGTGGGGAACTTTTAAAAATAGTATTCAAACTGATACACACACTTCACACTAGACGAAAGGGAAGATGGCTCTGGTTTGCTAGTGCAAGCCAATACAGC TAGAATGGGTCCCTGGATTCTTACCTCAGTCTGTTCCTACGGTCTCCCTAGGCCATGTGTATGTGTCCTGTCTTCATAGCATAGGTAGGAGATGGGAGATAACTGAGAAGATTGATGAAGACAGATCA AATACGTTTCCTCAGCTGTCTCCTACTACAGTTTTTAAGTTCTTTTAATCGGTCTTGTGGCAATGTGAGCTAAGAGGTGTGCAGAGATGATCACCCTTGGGTTTAGCAATGTTCCTAGAACCTCAAAT GACCACATAGTTAGAGGTCTGTAATATTCCCATATTAAGGACAGTCTTGGCAGCCATTCCTATTGTAGTAGCTACAAGATAACAGGTCCTTCTTTATCTAAAGGTTTCCAAATTCTCCCTATGCAAGT TCTTCCAGTAAACTAGGGTTTGGTAATTATGCCTGTGTTCTAACAGTGCTATCAAGATAATGGGATGGGGGGATGGCGAAGTGAAGGAGAAAGGAGGAAAAGGAGGGAGAGGAAAAGAGGGAGTAAGA AGATG
hide sequence
RefSeq Acc Id:
NP_872608 ⟸ NM_182667
- Peptide Label:
isoform 2
- UniProtKB:
Q7M6Y4 (UniProtKB/Swiss-Prot), Q8R5I8 (UniProtKB/Swiss-Prot), Q8R5I7 (UniProtKB/Swiss-Prot), A0A8I5ZYX5 (UniProtKB/TrEMBL)
- Sequence:
MTLLGSEHSLLIRRKFRSVLQLRLQQRRTQEQLANQGLIPPLKSPTEFHDPRKKLDSAKTEDSLRRKVRNRSDRASLVNMHILQASTAERSIPTAQMKLKRARLADDLNEKIALRPGPLELVEKNILP MDSSVKEAIKGTEVSLSKAADAFAFEDDSSRDGLSPDQARSEDPQGSGGSTPDIKSTEAPLAGPLDTIQDLTPGSESDKNDTASQLSNQSDSGKQVLGPLSTPIPVHTAVKSKSLGDSKNRHKKPKDP KPKVKKLKYHQYIPPDQKAEKSPPPMDSAYARLLQQQQLFLQLQILSQQQQQQQQQQQQQQQQQQQQRFSYPGMHQAHLKEPNEQMTRNPNSSSTPLNNTPLSPVKNSLSGQTGVSSLKPGPLPPNLD DLKVSELRQQLRIRGLPVSGTKTALVDRLRPFQDCAGNPVPNFGDITTVTFPVTPNTLPSYQSSPSGFYHFGSTSSSPPISPASSDLSAAGSLPDTFTDASPGFGLHASPVPACTDESLLSSLNGGSG PSEPDGLDSEKDKMLVEKQKVINQLTWKLRQEQRQVEELRMQLQKQKSGCNDQKPLPFLATTIKQEDVSSCPFAAQQASGKGQGHSSDSPPPACETAQLLPHCVESSGQTHVLSSTFLSPQCSPQHSP LGTLKSPQHISLPPSPNNHYFLASSSGAQRENHGVSSPNSSQGCAQMTGLQSSDKVGPTFSIPSPTFPKSSPTVPEITQPPSYEDAVKQQMTRSQQMDELLDVLIESGEMPADAREDHSCLQKIPKIP GSSCSPTTILPKSSASFEQASSGGQISFDHYATDSEEHLEVLLNSHSPIGKVSDVTLLKIGSEEPPFDGIMDGFPGKAAEDLFSAHELLPGPLSPMHTQLSPPSVDSSGLQLSFTESPWETMEWLDLT PPSSTPGFSNLTSSGPSIFNIDFLDVTDLNLNSPMDLHLQQW
hide sequence
RefSeq Acc Id:
XP_006246645 ⟸ XM_006246583
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I5ZYX5 (UniProtKB/TrEMBL)
- Sequence:
MHILQASTAERSIPTAQMKLKRARLADDLNEKIALRPGPLELVEKNILPMDSSVKEAIKGTEVS LSKAADAFAFEDDSSRDGLSPDQARSEDPQGSGGSTPDIKSTEAPLAGPLDTIQDLTPGSESDKNDTASQLSNQSDSGKQVLGPLSTPIPVHTAVKSKSLGDSKNRHKKPKDPKPKVKKLKYHQYIPP DQKAEKSPPPMDSAYARLLQQQQLFLQLQILSQQQQQQQQQQQQQQQQQQQQRFSYPGMHQAHLKEPNEQMTRNPNSSSTPLNNTPLSPVKNSLSGQTGVSSLKPGPLPPNLDDLKVSELRQQLRIRG LPVSGTKTALVDRLRPFQDCAGNPVPNFGDITTVTFPVTPNTLPSYQSSPSGFYHFGSTSSSPPISPASSDLSAAGSLPDTFTDASPGFGLHASPVPACTDESLLSSLNGGSGPSEPDGLDSEKDKML VEKQKVINQLTWKLRQEQRQVEELRMQLQKQKSGCNDQKPLPFLATTIKQEDVSSCPFAAQQASGKGQGHSSDSPPPACETAQLLPHCVESSGQTHVLSSTFLSPQCSPQHSPLGTLKSPQHISLPPS PNNHYFLASSSGAQRENHGVSSPNSSQGCAQNSGAHEGHPPSFSPPSSSLHQPFSGTQADSSHSSGLNPCPKSPVIHPKMTGLQSSDKVGPTFSIPSPTFPKSSPTVPEITQPPSYEDAVKQQMTRSQ QMDELLDVLIESGEMPADAREDHSCLQKIPKIPGSSCSPTTILPKSSASFEQASSGGQISFDHYATDSEEHLEVLLNSHSPIGKVSDVTLLKIGSEEPPFDGIMDGFPGKAAEDLFSAHELLPGPLSP MHTQLSPPSVDSSGLQLSFTESPWETMEWLDLTPPSSTPGFSNLTSSGPSIFNIDFLDVTDLNLNSPMDLHLQQW
hide sequence
Ensembl Acc Id:
ENSRNOP00000054372 ⟸ ENSRNOT00000057562
Ensembl Acc Id:
ENSRNOP00000072988 ⟸ ENSRNOT00000078675
Ensembl Acc Id:
ENSRNOP00000084177 ⟸ ENSRNOT00000109338
RefSeq Acc Id:
NP_001401161 ⟸ NM_001414232
- Peptide Label:
isoform 1
- UniProtKB:
A0A8I5ZYX5 (UniProtKB/TrEMBL), A0A0G2K4C5 (UniProtKB/TrEMBL)
RGD ID: 13697286
Promoter ID: EPDNEW_R7811
Type: single initiation site
Name: Myocd_1
Description: myocardin
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 10 51,779,041 - 51,779,101 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2010-04-23
Myocd
myocardin
Myocd
transcription factor myocardin
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2004-09-10
Myocd
transcription factor myocardin
Mycd
Symbol and Name updated
1299863
APPROVED